Table 3 Lymphocyte counts and lymphocyte subsets counts in blood and BAL.
CMV+ samples * | CMV-samples * | P value | |
|---|---|---|---|
Lymphocytes in blood † (/mm3) | 602 ± 75 | 590 ± 80 | NS |
CD2+ blood (/mm3) | 428 ± 64 [69 ± 4%] | 480 ± 73 [77 ± 3%] | NS |
CD3+ blood (/mm3) | 414 ± 64 [66 ± 4%] | 421 ± 61 [74 ± 3%] | NS |
CD4+ blood (/mm3) | 192 ± 39 [30 ± 3%] | 188 ± 29 [33 ± 3%] | NS |
CD8+ blood (/mm3) | 210 ± 32 [35 ± 3%] | 209 ± 28 [37 ± 3%] | NS |
CD19+ blood (/mm3) | 126 ± 23 [23 ± 3%] | 74 ± 13 [16 ± 3%] | 0.02 |
CD8/CD11a+ blood (/mm3) | 134 ± 26 [60 ± 5%] | 105 ± 17 [48 ± 5%] | NS |
NKH-1+ blood (/mm3) | 3 ± 0.8 [0.6 ± 0.15%] | 7.3 ± 1.9 [1.3 ± 0.3%] | 0.1 |
TiγA1 + blood (/mm3) | 5.7 ± 1.5 [1.1 ± 0.3%] | 25 ± 8 [3.4 ± 0.7%] | 0.08 |
Lymphocytes in BAL ‡ (× 103/ml) | 69.5 ± 19 | 27.4 ± 3.9 | 0.04 |
CD2+ BAL (× 103/ml) | 64.3 ± 19 [90 ± 3%] | 25.2 ± 3.7 [91 ± 1%] | 0.1 |
CD3+ BAL (× 103/ml) | 60.4 ± 18 [82 ± 3%] | 22.1 ± 4.2 [81 ± 3] | 0.1 |
CD4+ BAL (× 103/ml) | 11.6 ± 5.6 [14 ± 2%] | 4.2 ± 0.8 [18 ± 4%] | NS |
CD8+ BAL (× 103/ml) | 49.4 ± 13.2 [69 ± 4%] | 17.6 ± 3.9 [60 ± 7%] | 0.04 |
CD19+ BAL (× 103/ml) | 0.06 ± 0.03 [0.2 ± 0.01] | 0.1 ± 0.03 [0.5 ± 0.12] | NS |
CD8/CD11a+ BAL (× 103/ml) | 13 ± 7 [20 ± 10%] | 2 ± 0.5 [18 ± 10%] | NS |
NKH-1+ BAL (× 103/ml) | 1 ± 0.5 [1.7 ± 0.9%] | 0.3 ± 0.01 [1.3 ± 0.4%] | NS |
TiγA1+ BAL (× 103/ml) | 0.9 ± 0.4 [1.2 ± 0.3] | 1.2 ± 0.7 [4.4 ± 3%] | NS |